person:sally davies

  • Glasgow aims to be first ‘#smart_city’
    FT.com, By Sally Davies 03/06/2014
    http://www.ft.com/intl/cms/s/0/d119ac06-e57e-11e3-a7f5-00144feabdc0.html

    The Future Cities project in Glasgow has three main elements:

    Open Glasgow

    •An “intelligent operations platform” to store and analyse real-time and published data. People can access it via an online “dashboard” with widgets, smartphones apps and visualisations.
    •A “MyGlasgow” smartphone app that allows users to report problems such as uncollected bins and potholes and follow the progress of their report. The council receives about 26,000 calls a year for potholes but because of the difficulty identifying where they are, a quarter of the work orders raised to fix them are duplicates. The app will let users tag potholes on their smartphone with a map and see which other users have made reports.
    •An “internet of things” in three districts, where physical objects such as lampposts and schools can be virtually monitored.
    •Hackathons for local developers to build apps from public council data. Winners so far include an app that gives emergency services detailed location information about a caller, an energy-reporting app for council buildings and an app to encourage children to exercise more by allowing them to compare progress on public walking paths with friends and offering rewards such as cinema tickets.

    Demonstration projects

    ●Transport: a digital monitoring service to optimise use of council vehicles that take elderly people and children to and from appointments and redeploy them to other departments when idle. Across a fleet of 165 buses, the experiment has saved 47,200 miles a year. In one case, the number of buses needed to take 27 children to school was reduced from 12 to 10.
    ●Cycling: an app to record cyclists’ journeys so the council knows where to fix and build cycle lanes.
    ●Street lights: lamps that can measure air pollution, lighting levels and footfall. They can cut energy consumption up to 60 per cent by dimming when no one is around. They will also be able to light up an area if they detect trouble: this has been shown to reduce the number of fights.
    ●Energy: 3D modelling of city buildings and sensors in public housing to improve energy efficiency, as well as mapping 400 patches of empty land with a view to installing solar panels.

    Operations centre

    ●A control room for the city with new high-definition #CCTV, traffic cameras and data that will be coming in from new installations and apps. It has already been used to co-ordinate the response to a helicopter that crashed into a pub in central Glasgow last year, killing 10 people. [existe aussi à Rio]
    ●Sensors installed in the homes of elderly people in council housing, with their consent, will allow observers to “tell when they’ve got up in the morning, what rooms they’re using and manage how warm and deep the bath is”, says Phil Walker, who oversees the centre.
    ●New software that can build a picture of a face, based on witness descriptions and photographs.
    ●Research with the University of Strathclyde on a project that aims to use algorithms to predict crime.

    #opendata #surveillance #microsoft

    Et pour une autre vision de Glasgow :
    http://seenthis.net/messages/259597

  • Imagining the Post-Antibiotics Future
    https://medium.com/editors-picks/892b57499e77

    Health authorities have struggled to convince the public that this is a crisis. In September, Dr. Thomas Frieden, the director of the U.S. Centers for Disease Control and Prevention, issued a blunt warning: “If we’re not careful, we will soon be in a post-antibiotic era. For some patients and some microbes, we are already there.” The chief medical officer of the United Kingdom, Dame Sally Davies — who calls antibiotic resistance as serious a threat as terrorism — recently published a book in which she imagines what might come next. She sketches a world where infection is so dangerous that anyone with even minor symptoms would be locked in confinement until they recover or die. It is a dark vision, meant to disturb. But it may actually underplay what the loss of antibiotics would mean.

    fr : http://www.ulyces.co/maryn-mckenna/a-quoi-ressemblera-un-monde-sans-antibiotique

    #santé #resistance_aux_antibiotiques #agriculture #élevage

  • les CRE, bactéries super-#résistantes aux antibiotiques, un #cauchemar de #santé_publique aux #Etats-Unis

    CDC Warns of Resistance ’Nightmare’ | Wired Science | Wired.com
    http://www.wired.com/wiredscience/2013/03/cre-cdc

    The underlying risk here is that effectively untreatable CRE will spread out from hospitals and into the wider world, where it will become vastly more common and much harder to detect. That is not an unreasonable fear (...)

    So what’s to be done? In their press push yesterday, the CDC reviewed six steps that they first published last year in a CRE Toolkit and want health care facilities to take (...) an important point is that none of this is required, and none of this is funded.

    • oui j’avais écrit sur le sujet :
      http://blog.mondediplo.net/2008-03-31-En-Afrique-du-sud-le-retour-de-la-tuberculose
      et récemment, @mdiplo a publié ce papier sur le tourisme médical qui évoque aussi le problème, en Inde :
      http://www.monde-diplomatique.fr/2012/12/SHAH/48473

      l’intérêt de l’article cité ci-dessus c’est de montrer comment le système sanitaire US, très en pointe par certains côtés (le mythique CDC d’Atlanta) est complètement à la ramasse pour ce qui est de la prévention dans ses propres hôpitaux

      (merci de m’avoir donné l’occasion de le préciser)

    • Partenariat public-privé pour résoudre le problème ?

      Chief Medical Officer Dame Sally Davies : Resistance to antibiotics risks health ’catastrophe’ to rank with terrorism and climate change
      http://www.independent.co.uk/news/science/chief-medical-officer-dame-sally-davies-resistance-to-antibiotics-ris

      The reason, Dame Sally says, is market failure – for Big Pharma, there is little money in expensively developing new compounds which will only be taken in short courses, compared to a drug for blood pressure, say, which may have lifelong use for patients. Addressing the “discovery void” is now the key problem, she says, which may have to be tackled internationally, and may involve governments intervening in the hitherto private sector of drug development.

      “We may have to work with the pharmaceutical companies in public-private partnerships, and we may have to do some development of antibiotics on a public basis,” she said.

      She gave the example of the Innovative Medicines Initiative, a joint undertaking between the European Union and the pharmaceutical industry which supports collaborative research to boost pharmaceutical innovation in Europe.